Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 23 Neoplasm Metastasis 18 Prostatic Neoplasms 12 Lung Neoplasms 10 Carcinoma, Renal Cell 10 Carcinoma, Hepatocellular 10 Melanoma 9 Carcinoma, Non-Small-Cell Lung 9 Sarcoma 8 Liver Neoplasms 8 Kidney Neoplasms 8 Pain 6 Colorectal Neoplasms 6 Esophageal Neoplasms 4 Triple Negative Breast Neoplasms 3 Thyroid Neoplasms 3 Small Cell Lung Carcinoma 3 Osteosarcoma 3 Keratosis, Actinic 3 Desmoid Tumors 3 Colonic Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Ductal, Breast 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2

Interventions

Gemcitabine 4 lenvatinib 3 durvalumab 3 Cisplatin 3 tislelizumab 2 sintilimab 2 pembrolizumab 2 toripalimab 1 titanium silicide 1 theasinensin A 1 surufatinib 1 sitravatinib 1 regorafenib 1 S 1 (combination) 1 Nivolumab 1 Injections 1 Folfox protocol 1 Fluorouracil 1 Cryosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Biliary Tract Cancer × Cryosurgery × Clear all

NCT05781074 2023-03-24

CASTLE-08

Fudan University

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡